Frequency of Use and Predictors of Cancer-Directed Surgery in the Management of Malignant Pleural Mesothelioma in a Community-Based (Surveillance, Epidemiology, and End Results [SEER]) Population-Reference-Cited by-同舟云学术

Frequency of Use and Predictors of Cancer-Directed Surgery in the Management of Malignant Pleural Mesothelioma in a Community-Based (Surveillance, Epidemiology, and End Results [SEER]) Population

Published:2010-10 Issue:10 Volume:5 Page:1649-1654
ISSN:1556-0864
Container-title:Journal of Thoracic Oncology
language:en
Short-container-title:Journal of Thoracic Oncology

Author:

Flores Raja M.,Riedel Elyn,Donington Jessica Scott,Alago William,Ihekweazu Ugonna,Krug Lee,Rosenzweig Kenneth,Adusumilli Prasad S.,Carbone Michele,Pass Harvey I.

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine,Oncology

Reference18 articles.

1. Induction chemotherapy, extrapleural pneumonectomy, and postoperative high dose radiotherapy for locally advanced malignant pleural mesothelioma: a phase II trial;Flores;J Thorac Oncol,2006

2. Multicenter phase II trial of neoadjuvant pemetrexed plus cisplatin followed by extrapleural pneumonectomy and radiation for malignant pleural mesothelioma;Krug;J Clin Oncol,2009

3. Neoadjuvant chemotherapy followed by extrapleural pneumonectomy in malignant pleural mesothelioma;Weder;J Clin Oncol,2004

4. Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma;Vogelzang;J Clin Oncol,2003

5. Randomized Phase III Study of Cisplatin With or Without Raltitrexed in Patients With Malignant Pleural Mesothelioma: An Intergroup Study of the European Organisation for Research and Treatment of Cancer Lung Cancer Group and the National Cancer Institute of Canada

Cited by 72 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Predicting survival for patients with mesothelioma: development of the PLACE prognostic model;BMC Cancer;2023-07-26

2. Disparities in Survival Due to Social Determinants of Health and Access to Treatment in US Patients With Operable Malignant Pleural Mesothelioma;JAMA Network Open;2023-03-23

3. Improving outcomes in malignant pleural mesothelioma in an integrated health care system;Journal of Thoracic Disease;2022-09

4. Epidemiologie, Diagnostik und Therapie des Pleuramesothelioms;InFo Hämatologie + Onkologie;2022-07-28

5. Downregulation of FTL decreases proliferation of malignant mesothelioma cells by inducing G₁ cell cycle arrest;Oncology Letters;2022-04-13